Loading…
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 9,062 other HR bills in the 116th — cohort avg 39d
Patient Access to Cellular Transplant Act or the PACT Act This bill specifies that payment under Medicare to a hospital for the acquisition costs of an allogeneic hematopoietic stem cell transplant (e.g., bone marrow transplant from a donor) must be made on a reasonable cost basis (similar to the current payment methodology for solid organ acquisitions). The Centers for Medicare & Medicaid Services must determine included items through regulations.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (6)
2019 · fourth_quarter · Medicare/Medicaid
Referred to the House Committee on Ways and Means.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
CMS coding and billing clarity for CAR-T therapies; CMS engagement on FY2021 new DRG for CAR-T Therapies H.R. 2498, the PACT Act
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2019 · fourth_quarter · Medical/Disease Research/Clinical Labs
Appropriations, CAR-T Therapy clarification H.R. 2498, the PACT Act
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2019 · fourth_quarter · Health Issues
ASTCT appropriations; billing and coding; CAR-T Therapy clarifications H.R. 2498, the PACT Act
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2019 · fourth_quarter · Medicare/Medicaid
Inpatient hospital prospective payment system transplant reimbursement issues and proposed rule; S. 1268/H.R. 2498, the Patient Access to Cellular Transplant Act; H.R. 1865 FY2020 Further Consolidated Appropriations Act (LHHSED, AG, Energy Water, Interior, Leg. Branch, MCVA, State-For. Ops, T-HUD), Pub. L. No. 116-94.
Client expense: Not reported · Firm income: $69,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
2019 · fourth_quarter · Medicare/Medicaid
The Protect Access to Cellular Transplant Act (H.R. 2498), all provisions; The Protect Access to Cellular Transplant Act (S. 1286), all provisions; The Advancing Access to Precision Medicine Act (H.R. 4393), all provisions.
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2019 · fourth_quarter · Health Issues
Support for the Patient Access to Cellular Transplant (PACT) Act (S. 1286/H.R. 2498).
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · fourth_quarter · Medicare/Medicaid
Patient Access to Cellular Transplant (PACT) Act (S. 1268/H.R. 2498) Coverage of blood transfusions under Medicare Hospice Benefit Reimbursement for CAR-T/cellular and gene therapies Implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) CMS national coverage determinations Medicaid coverage for sickle cell disease Issues impacting opioid access/use for patients with hematologic diseases and disorders Improving Seniors Timely Access to Care Act of 2019 (H.R. 3107) Executive Order on Protecting and Improving Medicare for Our Nations Seniors; provision re: supervision and reimbursement of nonphysician professionals
Client expense: $30,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, White House Office
2019 · third_quarter · Medicare/Medicaid
Inpatient hospital prospective payment system transplant reimbursement issues and proposed rule; S. 1268/H.R. 2498, the Patient Access to Cellular Transplant Act
Client expense: Not reported · Firm income: $69,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
2019 · third_quarter · Health Issues
ASTCT appropriations; billing and coding; CAR-T Therapy clarifications H.R. 2498, the PACT Act
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2019 · third_quarter · Medical/Disease Research/Clinical Labs
Appropriations, CAR-T Therapy clarification H.R. 2498, the PACT Act
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2019 · third_quarter · Medicare/Medicaid
CMS coding and billing clarity for CAR-T therapies; CMS engagement on National Coverage Decision for CAR-T therapies H.R. 2498, the PACT Act
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2019 · third_quarter · Medicare/Medicaid
Medicare reimbursement issues, generally H.R.2498/S.1268, Patient Access to Cellular Transplant (PACT) Act, Medicare reimbursement issues
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · third_quarter · Medicare/Medicaid
Patient Access to Cellular Transplant (PACT) Act (S. 1268/H.R. 2498) Coverage of blood transfusions under Medicare Hospice Benefit Reimbursement for CAR-T/cellular and gene therapies Implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) CMS national coverage determinations Medicaid coverage for sickle cell disease Issues impacting opioid access/use for patients with hematologic diseases and disorders Impact of lowering poverty line on access to Medicaid and CHIP Improving Seniors Timely Access to Care Act of 2019 (H.R. 3107)
Client expense: $30,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), Office of Management & Budget (OMB), SENATE
2019 · second_quarter · Medicare/Medicaid
Inpatient hospital prospective payment system transplant reimbursement issues and proposed rule; S. 1268/H.R. 2498, the Patient Access to Cellular Transplant Act
Client expense: Not reported · Firm income: $69,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
2019 · second_quarter · Medicare/Medicaid
Patient Access to Cellular Transplant (PACT) Act (S. 1268/H.R. 2498) Coverage of blood transfusions under Medicare Hospice Benefit Reimbursement for CAR-T/cellular and gene therapies Implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) CMS national coverage determinations Medicaid coverage for sickle cell disease Issues impacting opioid access/use for patients with hematologic diseases and disorders Impact of lowering poverty line on access to Medicaid and CHIP
Client expense: $30,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), Office of Management & Budget (OMB), SENATE
2019 · second_quarter · Medicare/Medicaid
Medicare reimbursement issues, generally H.R.2498/S.1268, Patient Access to Cellular Transplant (PACT) Act, Medicare reimbursement issues
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| Democratic |
| MD |
| Dean Phillips | Democratic | MN |
| Doris O. Matsui | Democratic | CA |
| Earl Blumenauer | Democratic | OR |
| Eric Swalwell | Democratic | CA |
| Gus M. Bilirakis | Republican | FL |
| Harley Rouda | Democratic | CA |
| Jackie Walorski | Republican | IN |
| Jason Smith | Republican | MO |
| Joe Neguse | Democratic | CO |
| John Lewis | Democratic | GA |
| Josh Gottheimer | Democratic | NJ |
| Judy Chu | Democratic | CA |
| Ken Calvert | Republican | CA |
| Kenny Marchant | Republican | TX |
| Kurt Schrader | Democratic | OR |
| Mike Thompson | Democratic | CA |
| Pete Aguilar | Democratic | CA |
| Peter A. DeFazio | Democratic | OR |
| Richard Hudson | Republican | NC |
| Ro Khanna | Democratic | CA |
| Roger Marshall | Republican | KS |
| Sean Casten | Democratic | IL |
| Ted Budd | Republican | NC |
| Terri A. Sewell | Democratic | AL |
| Theodore E. Deutch | Democratic | FL |
| Tom Emmer | Republican | MN |
| Tom McClintock | Republican | CA |
| Zoe Lofgren | Democratic | CA |